Target intelligence / Profile preview

Disulfide bonds in mucins and biofilm extracellular polymeric substances

Molecular classification
Structural component, Chemical bond, Other
01

Overview

Disulfide bonds are critical covalent cross-links that stabilize the three-dimensional architecture of mucin glycoproteins and the extracellular polymeric substances (EPS) of bacterial biofilms. In mucins, these bonds link cysteine-rich domains of monomeric subunits to form massive, viscoelastic polymers that constitute the primary structural framework of mucus (PubMed: 24951272). In biofilms, disulfide bonds contribute to the stability of the proteinaceous matrix, protecting bacterial colonies from host immune responses and antibiotic penetration (PubMed: 30254116). Therapeutically, these bonds are targeted by mucolytic agents, such as N-acetylcysteine, which utilize free thiol groups to reduce the disulfide bridges into individual sulfhydryl groups (StatPearls: NBK537183). This chemical reduction breaks down the high-molecular-weight polymers, significantly decreasing the viscosity of pathological mucus and destabilizing the biofilm matrix. This approach is vital in treating respiratory conditions like cystic fibrosis and COPD, as well as in disrupting persistent bacterial infections.

Other names
Mucin disulfide bridgesEPS disulfide cross-linksCystine linkagesDisulfide cross-links
02

Mechanism of action

Reduction of disulfide bonds via thiol-disulfide exchange, leading to the cleavage of high-molecular-weight mucin polymers and biofilm matrix proteins into smaller, less viscous subunits.

03

Biological functions

Mucus gel formationBiofilm matrix stabilizationViscoelasticity regulationProtective barrier maintenance
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary diseaseChronic bronchitisBiofilm-associated infectionsBronchiectasis
05

Safety considerations

BronchospasmGastrointestinal irritationDisruption of protective mucosal barriersSulfur-like odorInactivation of certain antibiotics
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Sputum viscosityMucociliary clearance rateBiofilm biomass reductionForced expiratory volume in 1 second (FEV1)

Beyond the preview

Go deeper on Disulfide bonds in mucins and biofilm extracellular polymeric substances.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide bonds in mucins and biofilm extracellular polymeric substances.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call